Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland
An Infectious Diseases Physician and Clinical Microbiologist, Prof Paul Griffin was appointed as the Director of Infectious Diseases at Mater Health Services in 2013, and most recently, to his conjoint role as Head of the Mater Clinical Unit for the University of Queensland School of Medicine.
Prof Griffin is an accomplished clinical trial investigator, having fulfilled the role of Principal Investigator in over 150 clinical trials, particularly in Infectious Diseases including 8 COVID-19 vaccines. Despite an already demanding role at the Mater, Prof Griffin continues as a member of the AMA Queensland Council 2023-2024, and as board member and scientific advisory board member of the Immunisation Coalition, with active interest in vaccine education and advocacy, becoming a trusted media authority and spokesperson across the nation during the COVID-19 pandemic.
This mosquito-transmitted disease has already killed a handful of people, and is likely to become more common- an effective vaccine will soon be made widely available to those at risk.
In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).
Learn how to educate your older patients on how to stay protected from COVID-19, as well as vaccination tips, the role of antivirals in reducing severe COVID infection, managing risks for vulnerable patients, and practical prevention strategies in this latest podcast
Podcasts
Videos
